Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
The VA’s Foreign Medical Program covers medically necessary treatment for service-connected conditions, regardless of where a veteran lives or travels.
A majority of teacher-preparation programs now give aspiring educators opportunities to practice all essential components of reading instruction—but many still train educators in outdated or ...
When a patient with cancer tells their clinician they smoke, Andrea C. King, PhD, wants alarm bells to ring inside the exam ...
Proscia ® today introduced the Fifth Generation of its Concentriq ® 1 platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to ...
Seven candidates vying to become governor addressed a large audience in Pewaukee Monday night at a forum organized by WISDOM, ...
Drug harm reduction advocates says there is little evidence that methamphetamine is more harmful in the ACT since being decriminalised, despite a Canberra Liberals commitment to recriminalise it if ...
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
A version of this essay appeared on Matthew Yglesias’ Slow Boring, a site dedicated to offering pragmatic takes on politics ...
Sarepta Therapeutics faces a challenging outlook, with 2025 marked by safety setbacks, missed endpoints, and a sharp price decline. See why SRPT stock is a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results